HOME ABOUT US NEWS SCIENCE MILESTONES REGULATIONS CONTACT US
ABOUT US

Hong Kong Regen Medtech Limited

Pioneering the future of regenerative medicine through stem cell technology

Our Story

Hong Kong Regen Medtech Limited (HKRM) is a stem cell biotechnology company dedicated to developing stem cell therapies for intractable diseases. Through harnessing the therapeutic potential of stem cells, HKRM is developing new medicine targeting degenerative and immunological diseases. HKRM engineers stem cell manipulation and differentiation platform mimicking native developmental niches to generate high-quality cell therapy products.

Our Mission

To establish state-of-the-art stem cell therapies in Asia, complying with the highest standard of the industry

Our Vision

To help people achieve their desire for healthy longevity through stem cell therapies

Founding Members

HKRM’s founding and governance leadership combines cross-sector business experience with a long-term industry vision to support the clinical translation of regenerative medicine and stem cell innovation.

Mr. Cheng Chi-Heng, Conroy 鄭志恒先生
Chairman & Co-Founder
Mr. Cheng Chi-Heng, Conroy
Chairman & Co-Founder, HKRM

Mr. Cheng Chi-Heng, Conroy is Chairman and Co-Founder of HKRM. He is Vice-chairman and Executive Director of Chow Tai Fook Jewellery Group Limited, and a director of Chow Tai Fook (Holding) Limited and Chow Tai Fook Enterprises Limited. He also serves as a Non-executive Director of New World Development Company Limited. With extensive experience in corporate strategy, transformation, investment and cross-sector business development, Mr. Cheng supports HKRM’s mission to advance regenerative medicine and stem cell innovation in Hong Kong and beyond.

Vice-chairman & Executive Director, Chow Tai Fook Jewellery Group Limited
Director, Chow Tai Fook (Holding) Limited and Chow Tai Fook Enterprises Limited
Non-executive Director, New World Development Company Limited
Mr. Sy Ming Yiu, Stanley 施明耀先生
Co-Founder & CEO
Mr. Sy Ming Yiu, Stanley
Co-Founder & CEO, HKRM

Mr. Sy Ming Yiu, Stanley is Co-Founder and CEO of HKRM. He has more than a decade of experience in biotechnology, oncology diagnostics and innovative healthcare. A biomedical engineering graduate of The Chinese University of Hong Kong, he previously worked at Prince of Wales Hospital and later led Sanomics Limited as Chief Executive Officer and Executive Director. He also founded Aurora Tele-Oncology Limited and Alpha Life Company Limited. At HKRM, Mr. Sy drives business strategy, clinical translation and partnerships to advance stem cell research and applications.

Former CEO & Executive Director, Sanomics Limited
Founder, Aurora Tele-Oncology Limited and Alpha Life Company Limited
Biomedical Engineering graduate, The Chinese University of Hong Kong

Partner With Us

Learn more about HKRM's innovative stem cell therapies and partnership opportunities

Contact Us